Genomic diagnosis and multisystem phenotyping in pediatric congenital analbuminemia: clinical, coagulation, and immune signatures - Report - MDSpire

Genomic diagnosis and multisystem phenotyping in pediatric congenital analbuminemia: clinical, coagulation, and immune signatures

  • By

  • Asena Pinar Sefer

  • Melek Yorgun Altunbas

  • Baran Erman

  • Salim Can

  • Alper Bulutoglu

  • Satanay Hubrack

  • Katherine Ford

  • Melanie Makhlouf

  • Luis R. Saraiva

  • Gizem Onder

  • Ozden Hatirnaz

  • Ayse Merve Usta

  • Dilek Guller

  • Dilek Baser

  • Gamze Akgun

  • Umran Aba

  • Rahmi Kutay Erdogan

  • Omer Faruk Beser

  • Fugen Cullu Cokugras

  • Fatma Demirbas Ar

  • Nafiye Urganci

  • Oguz Salih Dincer

  • Sevgi Bilgic Eltan

  • Safa Baris

  • Elif Karakoc-Aydiner

  • Bernice Lo

  • Ahmet Ozen

  • June 2, 2026

  • 0 min

Share

Clinical Report: Genomic Assessment and Comprehensive Phenotyping of Pediatric Congenital Analbuminemia

Overview

This study investigates the clinical, coagulation, and immune profiles of five pediatric patients with congenital analbuminemia (CAA), revealing significant multisystem manifestations. Findings indicate that CAA is associated with increased thrombotic risk and immune dysregulation, challenging its historical classification as a benign condition.

Background

Congenital analbuminemia (CAA) is a rare autosomal recessive disorder characterized by severely reduced serum albumin levels due to mutations in the ALB gene. Despite being historically viewed as benign, recent evidence suggests that CAA can lead to serious multisystem complications, including thrombotic events and recurrent infections. Understanding the clinical implications of CAA is crucial for timely diagnosis and management in affected pediatric patients.

Data Highlights

Five pediatric patients with genetically confirmed CAA were studied, revealing persistent hypoalbuminemia, early-onset edema, and significant thrombotic and immune dysregulation.

Key Findings

  • All patients exhibited persistent hypoalbuminemia and early-onset edema.
  • Gastrointestinal morbidity often led to misdiagnosis as protein-losing enteropathy.
  • Coagulation profiling showed a prothrombotic signature with elevated fibrinogen and D-dimer levels.
  • One patient experienced life-threatening cerebral thrombosis.
  • Immunological evaluation indicated preserved leukocyte counts but skewed CD4⁺ T cell profiles.

Clinical Implications

Early molecular diagnosis of CAA can prevent unnecessary invasive procedures and guide individualized monitoring for thrombotic and infectious complications. Clinicians should be aware of the multisystem implications of CAA, including its potential to cause significant morbidity in pediatric patients.

Conclusion

This study underscores the importance of recognizing the complex clinical profile of pediatric CAA, advocating for early diagnosis and comprehensive management strategies to address its multisystem effects.

Related Resources & Content

  1. Frontiers in Pediatrics, 2026 -- Clinical utility of an evolving cholestasis gene panel in 10,000 children and adults
  2. Frontiers in Pediatrics, 2026 -- Genotype-Phenotype Correlations in EPCAM-Associated Congenital Tufting Enteropathy: A Case Report and Systematic Review
  3. Intensive Care Medicine, 2019 -- Comprehensive Genome Analysis Indicates High Prevalence of Genetic Disorders in Critically Ill Pediatric Patients
  4. The Journal of Clinical Endocrinology & Metabolism -- Does the Integration of Molecular Testing Enhance the Precision of Newborn Screening for Congenital Adrenal Hyperplasia?
  5. Curation results for Gene-Disease Validity, 2025 -- Congenital analbuminemia
  6. Genetics in Medicine -- Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
  7. Frontiers, 2019 -- Diagnosis, Phenotype, and Molecular Genetics of Congenital Analbuminemia
  8. curation results for Gene-Disease Validity
  9. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG) | Genetics in Medicine
  10. Frontiers | Diagnosis, Phenotype, and Molecular Genetics of Congenital Analbuminemia

Original Source(s)

Related Content